UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Lifted by Pure Financial Advisors LLC

Pure Financial Advisors LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 31.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,831 shares of the healthcare conglomerate's stock after purchasing an additional 1,157 shares during the quarter. Pure Financial Advisors LLC's holdings in UnitedHealth Group were worth $2,530,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in the business. Norges Bank acquired a new stake in UnitedHealth Group during the fourth quarter worth about $6,375,744,000. GAMMA Investing LLC grew its stake in shares of UnitedHealth Group by 56,142.1% in the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after buying an additional 8,280,404 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $1,914,740,000. Amundi grew its stake in shares of UnitedHealth Group by 97.2% in the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock valued at $3,183,132,000 after buying an additional 2,991,470 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of UnitedHealth Group by 36.6% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock worth $4,346,712,000 after acquiring an additional 2,301,010 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have recently weighed in on UNH. KeyCorp dropped their price target on UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a research report on Monday, June 2nd. Deutsche Bank Aktiengesellschaft dropped their price target on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research report on Wednesday, May 14th. Truist Financial reiterated a "buy" rating and set a $360.00 price target (down from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. HSBC reiterated a "reduce" rating and set a $270.00 price target (down from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Finally, Wolfe Research cut their target price on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 20th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $415.57.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,533 shares of the company's stock in a transaction that occurred on Wednesday, May 14th. The shares were purchased at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the transaction, the director now owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the company's stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the transaction, the chief executive officer now directly owns 679,493 shares of the company's stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 109,408 shares of company stock valued at $31,607,768 over the last three months. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Price Performance

Shares of UNH traded up $6.23 during midday trading on Friday, reaching $308.85. The stock had a trading volume of 13,584,804 shares, compared to its average volume of 7,465,895. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The firm's 50 day moving average price is $339.15 and its 200-day moving average price is $456.28. The company has a market capitalization of $280.17 billion, a P/E ratio of 12.93, a P/E/G ratio of 1.43 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same period in the prior year, the firm posted $6.91 EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.86%. UnitedHealth Group's payout ratio is 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.